(Q37636150)

21 August 2017

1 reference

title

New information about the polymyxin/colistin class of antibiotics (English)

1 reference

21 August 2017

2

Elisa Cordero

1 reference

21 August 2017

José Molina

1

1 reference

21 August 2017

Jerónimo Pachón

series ordinal

3

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

Expert Opinion on Pharmacotherapy

21 August 2017

published in

1 reference

21 August 2017

volume

10

1 reference

21 August 2017

issue

17

1 reference

21 August 2017

page(s)

2811-2828

1 reference

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Toxicity of polymyxins: a systematic review of the evidence from old and recent studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest and time-kill assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Use of international units when dosing colistin will help decrease confusion related to various formulations of the drug around the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Defining the dosage units for colistin methanesulfonate: urgent need for international harmonization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Ventilator-associated pneumonia due to colistin susceptible-only microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Early intervention and prevention of lung disease in cystic fibrosis: a European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Management of meningitis due to antibiotic-resistant Acinetobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Declining susceptibility to neomycin and polymyxin B of pathogens recovered in otitis externa clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Toxicity after prolonged (more than four weeks) administration of intravenous colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Polymyxin B nephrotoxicity and efficacy against nosocomial infections caused by multiresistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Bronchoconstriction following nebulised colistin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Bronchial constriction and inhaled colistin in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903334185

10.1517/14656560903334185

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference